Skip to main content
Premium Trial:

Request an Annual Quote

Floragenex and BioDiagnostics to Offer Sequencing-Based SNP Discovery, Genotyping Services

Premium

Plant science companies Floragenex and BioDiagnostics have partnered to offer their sequencing-based SNP discovery and genotyping services to customers in the seed industry, the companies said last week.

Under the agreement, BDI customers will have access to Floragenex' DNA sequencing and molecular marker discovery services, while Floragenex customers can use testing and genotyping services offered by BDI.

Floragenex, based in Eugene, Ore., has developed a sequencing-based method that allows researchers to gain SNP information for species whose genomes have not yet been sequenced.

The method, called Restriction site Associated DNA, or RAD, LongRead sequencing, analyzes DNA around restriction enzyme sites and generates contigs up to 600 bases in length from Illumina Genome Analyzer sequence data. According to the company's website, this is enough flanking sequence to design effective assays on "any of the leading commercial genotyping platforms."

The two companies plan initially to collaborate on projects for customers in the agronomic and vegetable crop markets.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.